E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
27 / 12 / 2022

 


Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management

Bhagwan Singh Meena, Mahesh Kumar, Shubhangi Anand Kale.


Abstract
Background: The prevalence of chronic renal failure has increased, as has the need for renal replacement therapy, as both diabetes and hypertension have become more prevalent. Patients’ mortality rates from cardiac causes have increased despite effective monitoring and care. Dyslipidemia significantly contributes to the risk of arteriosclerotic cardiovascular disease, the main cause of death in people with chronic kidney disease (CKD).

Aims and Objectives: The objectives of this study were to measurement of hyperlipidemia in patients with CKD on hemodialysis/conservative management.

Materials and Methods: The investigation was conducted on 250 patients with CKD at all stages who were receiving hemodialysis and conservative of both sexes aged 20 years or more and sex-matched healthy control subjects. Lipid profiles of each subject were measured in specimens.

Results: In our study, dyslipidemia was identified as having high levels of total cholesterol, triglycerides, and low-density lipoprotein and low levels of high-density lipoprotein.

Conclusion: The significance of dyslipidemia as a standalone risk factor for coronary artery disease (CAD) in CKD patients was examined in this study. Hence, based on the evidence presented above, we conclude that close monitoring of the ideal cholesterol levels in CKD patients is necessary to reduce the risk of CAD-related death. In CKD patients, monitoring and treating dyslipidemia can reduce mortality.

Key words: Chronic Kidney Disease; Hypertriglyceridemia; Lipid Profile; Dyslipidemia; Coronary Artery Disease


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bhagwan Singh Meena
Articles by Mahesh Kumar
Articles by Shubhangi Anand Kale
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022


Web Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. https://www.njppp.com/?mno=101443 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.12597202220122022


AMA (American Medical Association) Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022



Vancouver/ICMJE Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. (2023), [cited March 14, 2024]; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022



Harvard Style

Meena, B. S., Kumar, . M. & Kale, . S. A. (2023) Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022



Turabian Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. 2023. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022



Chicago Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. "Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 367-369. doi:10.5455/njppp.2023.13.12597202220122022



MLA (The Modern Language Association) Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. "Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 367-369. Print. doi:10.5455/njppp.2023.13.12597202220122022



APA (American Psychological Association) Style

Meena, B. S., Kumar, . M. & Kale, . S. A. (2023) Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022